Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Nanoviricides, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 48 | 47 | −1 |
| Shares | 1.90M | 2.37M | +471.4K (+24.8%) |
| Value | $1.73M | $3.27M | +$1.54M (+88.9%) |
New holders (8)
Institutions that held Nanoviricides, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 185,217 | $255.6K | 0.18% |
| Creative Planning | 86,761 | $119.7K | 0.00% |
| Two Sigma Securities, LLC | 13,816 | $19.1K | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,200 | $1.66K | 0.00% |
| Action Point Financial Planning, LLC | 575 | $793 | 0.00% |
| Wells Fargo & Company | 500 | $690 | 0.00% |
| Northwestern Mutual Wealth Management Co | 50 | $69 | 0.00% |
| Institute for Wealth Management, LLC. | 10 | $14 | 0.00% |
Sold out (9)
Institutions that held Nanoviricides, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Squarepoint Ops LLC | 58,138 | $53.0K |
| XTX Topco Ltd | 35,432 | $32.3K |
| Jane Street Group, LLC | 23,755 | $21.7K |
| Virtu Financial LLC | 12,160 | $11.0K |
| Curio Wealth, LLC | 2,000 | $1.82K |
| Sittner & Nelson, LLC | 1,000 | $913 |
| Bernard Wealth Management Corp. | 500 | $457 |
| Sound Income Strategies, LLC | 300 | $286 |
| Caitong International Asset Management Co., Ltd | 1 | $1 |